Advancing Pharmacogenomics from Single-Gene to Preemptive Testing

被引：35

作者：

Haidar, Cyrine E. ^{[1
]}

Crews, Kristine R. ^{[1
]}

Hoffman, James M. ^{[1
,2
]}

Relling, Mary, V ^{[1
]}

Caudle, Kelly E. ^{[1
]}

机构：

[1] St Jude Childrens Res Hosp, Dept Pharm & Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA

[2] St Jude Childrens Res Hosp, Off Qual & Safety, 332 N Lauderdale St, Memphis, TN 38105 USA

来源：

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS | 2022年 / 23卷

基金：

美国国家卫生研究院;

关键词：

pharmacogenetics; pharmacogenomics; precision medicine; individualized medicine; personalized medicine; clinical decision support; genomic medicine; CLINICAL DECISION-SUPPORT; IMPLEMENTATION CONSORTIUM; PRECISION MEDICINE; INCIDENTAL FINDINGS; HEALTH-CARE; UNIVERSITY; POINT; OUTCOMES; INTEGRATION; STRATEGIES;

D O I：

10.1146/annurev-genom-111621-102737

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Pharmacogenomic testing can be an effective tool to enhance medication safety and efficacy. Pharmacogenomically actionable medications are widely used, and approximately 90-95% of individuals have an actionable genotype for at least one pharmacogene. For pharmacogenomic testing to have the greatest impact on medication safety and clinical care, genetic information should be made available at the time of prescribing (preemptive testing). However, the use of preemptive pharmacogenomic testing is associated with some logistical concerns, such as consistent reimbursement, processes for reporting preemptive results over an individual's lifetime, and result portability. Lessons can be learned from institutions that have implemented preemptive pharmacogenomic testing. In this review, we discuss the rationale and best practices for implementing pharmacogenomics preemptively.

引用

页码：449 / 473

页数：25

共 150 条

[61] Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy [J].

Harada, S. ;

Zhou, Y. ;

Duncan, S. ;

Armstead, A. R. ;

Coshatt, G. M. ;

Dillon, C. ;

Brott, B. C. ;

Willig, J. ;

Alsip, J. A. ;

Hillegass, W. B. ;

Limdi, N. A. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (03) :493-501

[62] Identification of populations likely to benefit from pharmacogenomic testing [J].

Heise, Craig William ;

Gallo, Tyler ;

Curry, Steven C. ;

Woosley, Raymond L. .

PHARMACOGENETICS AND GENOMICS, 2020, 30 (05) :91-95

[63] Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update [J].

Hicks, J. K. ;

Sangkuhl, K. ;

Swen, J. J. ;

Ellingrod, V. L. ;

Muller, D. J. ;

Shimoda, K. ;

Bishop, J. R. ;

Kharasch, E. D. ;

Skaar, T. C. ;

Gaedigk, A. ;

Dunnenberger, H. M. ;

Klein, T. E. ;

Caudle, K. E. ;

Stingl, J. C. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (01) :37-44

[64] A Clinician-Driven Automated System for Integration of Pharmacogenetic Interpretations Into an Electronic Medical Record [J].

Hicks, J. K. ;

Crews, K. R. ;

Hoffman, J. M. ;

Kornegay, N. M. ;

Wilkinson, M. R. ;

Lorier, R. ;

Stoddard, A. ;

Yang, W. ;

Smith, C. ;

Fernandez, C. A. ;

Cross, S. J. ;

Haidar, C. ;

Baker, D. K. ;

Howard, S. C. ;

Evans, W. E. ;

Broeckel, U. ;

Relling, M. V. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (05) :563-566

[65] Integrating pharmacogenomics into electronic health records with clinical decision support [J].

Hicks, J. Kevin ;

Dunnenberger, Henry M. ;

Gumpper, Karl F. ;

Haidar, Cyrine E. ;

Hoffman, James M. .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (23) :1967-1976

[66] Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation Services [J].

Hicks, J. Kevin ;

Stowe, David ;

Willner, Marc A. ;

Wai, Maya ;

Daly, Thomas ;

Gordon, Steven M. ;

Lashner, Bret A. ;

Parikh, Sumit ;

White, Robert ;

Teng, Kathryn ;

Moss, Timothy ;

Erwin, Angelika ;

Chalmers, Jeffrey ;

Eng, Charis ;

Knoer, Scott .

PHARMACOTHERAPY, 2016, 36 (08) :940-948

[67] Biomedical Data Science and Informatics Challenges to Implementing Pharmacogenomics with Electronic Health Records [J].

Hoffman, James M. ;

Flynn, Allen J. ;

Juskewitch, Justin E. ;

Freimuth, Robert R. .

ANNUAL REVIEW OF BIOMEDICAL DATA SCIENCE, VOL 3, 2020, 2020, 3 :289-314

[68] Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC) [J].

Hoffman, James M. ;

Dunnenberger, Henry M. ;

Hicks, J. Kevin ;

Caudle, Kelly E. ;

Carrillo, Michelle Whirl ;

Freimuth, Robert R. ;

Williams, Marc S. ;

Klein, Teri E. ;

Peterson, Josh F. .

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2016, 23 (04) :796-801

[69] PG4KDS: A model for the clinical implementation of pre-emptive pharmacogenetics [J].

Hoffman, James M. ;

Haidar, Cyrine E. ;

Wilkinson, Mark R. ;

Crews, Kristine R. ;

Baker, Donald K. ;

Kornegay, Nancy M. ;

Yang, Wenjian ;

Pui, Ching-Hon ;

Reiss, Ulrike M. ;

Gaur, Aditya H. ;

Howard, Scott C. ;

Evans, William E. ;

Broeckel, Ulrich ;

Relling, Mary V. .

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2014, 166 (01) :45-55

[70] Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic? [J].

Huddart, Rachel ;

Sangkuhl, Katrin ;

Whirl-Carrillo, Michelle ;

Klein, Teri E. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (02) :284-286

← 2 3 4 5 6 7 8 9 10 11 →